Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design.
about
Up-regulation of p21 and TNF-alpha is mediated in lycorine-induced death of HL-60 cells.Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of pro-inflammatory HMGB1 from macrophagesSmac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent mannerThe role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damageCancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors.The emerging importance of DNA mapping and other comprehensive screening techniques, as tools to identify new drug targets and as a means of (cancer) therapy personalisation.Anticancer activity of taraxerol acetate in human glioblastoma cells and a mouse xenograft model via induction of autophagy and apoptotic cell death, cell cycle arrest and inhibition of cell migrationInterconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development.Osthole induces lung cancer cell apoptosis through inhibition of inhibitor of apoptosis family proteinsAutophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer.Effects of Tyroserleutide on phosphatidylinositol 3'-kinase/AKT pathway in human hepatocellular carcinoma cell.Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway.Butyrate increases apoptosis induced by different antineoplastic drugs in monocytic leukemia cells.Comparison of reproductive effects of levetiracetam and valproate studied in prepubertal porcine ovarian follicular cells.Effect of saw palmetto extract on PI3K cell signaling transduction in human glioma.Apoptotic effects of Physalis minima L. chloroform extract in human breast carcinoma T-47D cells mediated by c-myc-, p53-, and caspase-3-dependent pathways.Escitalopram oxalate induces apoptosis in U-87MG cells and autophagy in GBM8401 cells.Escitalopram oxalate inhibits proliferation and migration and induces apoptosis in non-small cell lung cancer cells.The Aspergillus fumigatus metacaspases CasA and CasB facilitate growth under conditions of endoplasmic reticulum stress.Flavonoids of Rosa roxburghii Tratt exhibit radioprotection and anti-apoptosis properties via the Bcl-2(Ca(2+))/Caspase-3/PARP-1 pathway.Millepachine, a novel chalcone, induces G2/M arrest by inhibiting CDK1 activity and causing apoptosis via ROS-mitochondrial apoptotic pathway in human hepatocarcinoma cells in vitro and in vivo.
P2860
Q33648570-19F6114F-7731-4BA8-B5E4-B98BA0C63976Q33946622-3ADEAEE8-B9A2-4EFD-8D4B-A3E72B168BA1Q35016039-6ADDB1F8-ED7F-43C4-BC4E-B8ED6F7601F9Q35464924-20B6ED31-1280-4AB2-B1D4-431A0B0018ABQ35609713-C3233591-D240-4000-9821-9938FF373176Q36425978-EE5E6391-4F87-4B53-9146-0BDD6F7EBD0EQ36931254-9027D774-E518-4D12-8365-D157619F4F9DQ37295309-F089E02E-ECEE-40C3-90F6-AB27E959D028Q37407173-FA6B9E53-76F6-4DCC-A430-6FFC4C60585DQ38066407-7FC32644-F7D1-43BF-864A-64457A44B958Q39074038-DB55482B-4F35-4EB5-B38D-D877A1E1D4CBQ40366348-038C8E02-B7C7-47B2-AA6F-A083ECE72D29Q40495190-1DEA6EF9-4B7D-41A1-9381-C92D018DED0AQ42501527-8063E47D-C6BB-4C43-943B-4289135EDDB0Q42718251-D6A89859-194D-4249-8C5B-94D963B233E5Q43164842-965FA10B-E548-403B-9EA9-4C06E8123A1FQ47985758-92BD7613-64B0-4075-9BD5-CA21D02A111AQ49494705-B428B0B9-8074-4ED0-839E-96F584FCF0B6Q52575717-B2FF0457-91CD-4BCA-A1E4-BB2C04320E1AQ53063367-6E587177-DBD7-450E-9369-B24D34462890Q54445373-AFC58308-422A-4BC2-A164-F63AB7C2C73D
P2860
Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design.
@ast
Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design.
@en
type
label
Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design.
@ast
Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design.
@en
prefLabel
Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design.
@ast
Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design.
@en
P2093
P1433
P1476
Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design.
@en
P2093
Andrzej Mackiewicz
Christof J Burek
Christopher Stroh
Hubert Hug
Konrad Benedyk
P356
10.1016/S1359-6446(02)02563-1
P50
P577
2003-01-01T00:00:00Z